Morepen Laboratories Limited, a pharmaceutical company founded on December 1st 1984, develops, manufactures and markets generic drugs and pharmaceutical formulations for domestic and international customers. The Company offers its products in different forms, such as tablets, capsules, injections, ointments, syrups, and powders. The company is headquartered in New Delhi.                                                                                     Â
Morepen Share Price Current Market Overview
- Today’s Open: 95.20
- Today’s High: 96.25
- Today’s Low: 92.10
- Current Share Price: 94.48
- Market Capital: 5.10kCr
- P/EÂ Â Â Â Â Â Â Â Â Â Â Â : 40.31
- Dividend Yield: N/A
- 52 Week High: 100.90
- 52 Week Low: 31.30
Morepen Share Price Current GraphÂ
Morepen Share Price Target Tomorrow From 2024 To 2030
The following table shows the share target price for upcoming years, which is based on market valuation, industrial trends, and expert predictions:
| Â Â Â Sr.No. | Â Â Â Year | Share Price Target |
| 1 | 2024 | Rs 102 |
| 2 | 2025 | Rs 154 |
| 3 | 2026 | Rs 212 |
| 4 | 2027 | Rs 262 |
| 5 | 2028 | Rs 325 |
| 6 | 2029 | Rs 385 |
| 7 | 2030 | Rs 445 |
Shareholding Pattern For Morepen Share Price
Morepen Laboratories has a numerous shareholding structure that shows market self-notion and investor hobby:
- Retail and Others: 53.73 %
- Promoters: 35.65 %
- Foreign Institutions: 7.72 %
- Other Domestic Institutions: 2.90%
Morepen Share Price Annual Income Statement
The given chart shows the comparison between revenue and net income.
Here are the details of the annual income statement of the company.
| Particulars | Info 2024 | Y/Y Change |
| Revenue | 4.59B | 13.68%(+) |
| Operating Expenses | 1.17B | 2.26%(+) |
| Net Income | 361.68M | 147.16% (+) |
| Net Profit Margin | 7.89 | 117.36% (+) |
| Earning Per Share | N/A | N/A |
| EBITDA | 537.86M | 93.64% (+) |
| Effective Tax Rate | 24.91% | N/A |
Risk And Challenges For Morepen Share Price
While the Morepen Share Price is positive, several dangers and challenges may additionally moreover want to impact its growth:
- Currency Fluctuation: As Morepen expands its global presence, it will be exposed to currency risk that could affect its financial performance.
- Market Competition: The pharmaceutical industry is highly competitive, with numerous players vying for market share. Morepen must continuously innovate and deliver high-quality products to maintain its position.
- Regulatory Risk: Changes in domestic and international policies, especially within the pharmaceutical sector, can impact Morepen’s operation and profitability.
- Dependency on Key Products: Morepen’s heavy reliance on specific APIs may pose a risk if demand for these products declines or if competitors introduce alternatives.
